Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 496

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 496
---
--------:|:----|:-------|--------:|:----|:-------|----------:|:----|:-------------|-------:|:----|:------|----------:|:--|
| Dr. James Bianco                      |     |        | 2024 |     |        | 463,734 |     |        |     [●] |     |        | 4,900,000 |     |              | 80,000 |     | $     |        [● | ] |
| President and Chief Executive Officer |     |        | 2023 |     |        | 439,834 |     |        | 579,668 |     |        |   192,000 |     |              |     83 |     | $     | 1,211,585 |   |
| Dan Dearborn                          |     |        | 2024 |     |        | 339,101 |     |        |     [●] |     |        | 2,200,000 |     |              |      — |     | $     |        [● | ] |
| Chief Financial Officer               |     |        | 2023 |     |        | 320,833 |     |        | 254,326 |     |        |    42,240 |     |              |    108 |     | $     |   635,775 |   |
| Dennis Yamashita(4)                   |     |        | 2024 |     |        | 320,833 |     |        |       — |     |        |   588,000 |     |              |      — |     | $     |   908,833 |   |
| Chief Scientific Officer              |     |        | 2023 |     |        |       — |     |        |       — |     |        |         — |     |              |      — |     |       |         — |   |

| (1) | Amounts in this column represent (i) discretionary annual incentive bonuses earned for performance in fiscal 2023, which were paid in 2024 and (ii) discretionary annual incentive bonuses earned for performance in fiscal 2024, which have not yet been paid. For more information regarding the annual bonuses, see “—Narrative Disclosure to Summary Compensation Table — Annual Bonuses” below. |

| (2) | Amounts in this column represent the aggregate grant date fair value